Daiwa Securities Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.21M | Buy |
|
|||||
|
2025
Q2 | $2.22M | Buy |
|
|||||
|
2025
Q1 | $2.29M | Buy |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $1.27M | Buy |
|
|||||
|
2024
Q2 | $1.39M | Buy |
|
|||||
|
2024
Q1 | $1.42M | Sell |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $1.72M | Sell |
|
|||||
|
2023
Q2 | $1.71M | Buy |
|
|||||
|
2023
Q1 | $1.9M | Sell |
|
|||||
|
2022
Q4 | $2.06M | Sell |
|
|||||
|
2022
Q3 | $2.3M | Buy |
|
|||||
|
2022
Q2 | $1.59M | Buy |
|
|||||
|
2022
Q1 | $1.47M | Buy |
|
|||||
|
2021
Q4 | $1.41M | Sell |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | $1.22M | Sell |
|
|||||
|
2021
Q1 | $1.15M | Sell |
|
|||||
|
2020
Q4 | $1.46M | Buy |
|
|||||
|
2020
Q3 | $863K | Buy |
|
|||||
|
2020
Q2 | $755K | Sell |
|
|||||
|
2020
Q1 | $1.6M | Buy |
|
|||||
|
2019
Q4 | $1.28M | Sell |
|
|||||
|
2019
Q3 | $1.65M | Buy |
|
|||||
|
2019
Q2 | $1.41M | Sell |
|
|||||
|
2019
Q1 | $1.57M | Buy |
|
|||||
|
2018
Q4 | $1.42M | Buy |
|
|||||
|
2018
Q3 | $685K | Buy |
|
|||||
|
2018
Q2 | $637K | Hold |
|
|||||
|
2018
Q1 | $549K | Buy |
|
|||||
|
2017
Q4 | $464K | Hold |
|
|||||
|
2017
Q3 | $484K | Buy |
|
|||||
|
2017
Q2 | $450K | Buy |
|
|||||
|
2017
Q1 | $430K | Buy |
|
|||||
|
2016
Q4 | $356K | Buy |
|
|||||
|
2016
Q3 | $352K | Hold |
|
|||||
|
2016
Q2 | $296K | Hold |
|
|||||
|
2016
Q1 | $313K | Buy |
|
|||||
|
2015
Q4 | $377K | Sell |
|
|||||
|
2015
Q3 | $1.22M | Sell |
|
|||||
|
2015
Q2 | $1.76M | Buy |
|
|||||
|
2015
Q1 | $474K | Hold |
|
|||||
|
2014
Q4 | $344K | Sell |
|
|||||
|
2014
Q3 | $1.3M | Sell |
|
|||||
|
2014
Q2 | $2.4M | Sell |
|
|||||
|
2014
Q1 | $3.04M | Buy |
|
|||||
|
2013
Q4 | $310K | Hold |
|
|||||
|
2013
Q3 | $318K | Buy |
|
|||||
|
2013
Q2 | $212K | Buy |
|